🎀  Charles H. Paul       |  πŸ“…  March 06, 2025    |  πŸ•’  11 AM Eastern Time US


Strengthen Clinical Trial Integrity with Risk-Based Monitoring


Why Wait? Secure Your Spot Today.





πŸš€ Do you fully understand how risk-based monitoring (RBM) enhances compliance?

πŸš€ Are your risk management practices aligned with FDA and ICH expectations?

πŸš€ Want expert insights on leveraging technology for clinical trial monitoring?


This must-attend webinar is designed for professionals involved in clinical trial monitoring, compliance, and risk management, including: 
πŸ‘©β€βš•οΈ Clinical Research Associates & Monitors – Optimize monitoring practices to ensure regulatory compliance.
πŸ“Š Data Management & Project Teams – Strengthen trial oversight with risk-based strategies.
πŸ›  Regulatory & Compliance Specialists – Ensure adherence to global clinical trial regulations.
🏭 Clinical Research Outsourcing & Drug Suppliers – Understand risk-based monitoring’s impact on clinical supply chains.
πŸ’‘ Trial Statisticians & Quality Assurance Teams – Leverage data-driven insights for enhanced trial quality. 

Applicable industries:
Pharmaceuticals | Biotech | Medical Devices | Contract Research Organizations (CROs) | Clinical Research


Ensuring patient safety, data integrity, and regulatory compliance in clinical trials is more challenging than ever. With evolving regulatory expectations, Risk-Based Monitoring (RBM) has emerged as a smarter, more efficient alternative to traditional monitoring methodsβ€”allowing organizations to identify, assess, and mitigate risks proactively. 

This expert-led webinar explores the intersection of Good Clinical Practice (GCP) and risk management, equipping participants with the knowledge to enhance compliance and monitoring effectiveness. Led by Charles H. Paul, a 30+ year industry expert, this session will provide practical strategies to implement risk-based monitoring, leverage technology, and develop a robust risk management plan.

What You’ll Learn: 

βœ” Master GCP Compliance – Understand the foundational principles of Good Clinical Practice (GCP) and how they impact risk management.
βœ” Navigate Regulatory Frameworks – Align risk management practices with FDA, EMA, ICH E6(R2), ISO 14155:2020, and 21 CFR Part 312 requirements.
βœ” Implement Risk-Based Monitoring (RBM) – Learn how to transition from traditional monitoring to a risk-based approach.
βœ” Develop a Robust Risk Management Plan – Identify, assess, and mitigate risks effectively using risk matrices and prioritization techniques.
βœ” Utilize Technology for Enhanced Monitoring – Discover tools and data analytics solutions that improve clinical trial oversight.
βœ” Mitigate Risks & Strengthen Compliance – Learn best practices to prevent protocol deviations, fraud, and regulatory non-compliance.

 Key Areas Covered

πŸ“Œ Introduction to Good Clinical Practice (GCP) & Risk Management
πŸ“Œ Regulatory Frameworks & Compliance Requirements – ICH E6(R2), ISO 14155:2020, 21 CFR Part 312
πŸ“Œ Common Risks in Clinical Trials – Patient safety, data accuracy, protocol deviations
πŸ“Œ Implementing Risk-Based Monitoring (RBM) – Transitioning from traditional monitoring approaches
πŸ“Œ Building a Risk Management Plan – Risk identification, categorization, and mitigation strategies
πŸ“Œ Leveraging Technology for Monitoring – AI-driven analytics, remote monitoring platforms


Read more